SCM
MED icon

Shelton Capital Management’s Medifast MED Stock Holding History

Shelton Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,065
Closed -$236K – 853
2018
Q3 		$236K Buy
+1,065
New +$216K 0.01% 745

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Shelton Capital Management's MED Position: Q4 2018 in Review

Shelton Capital Management sold out of Medifast (MED) in Q4 2018, closing a stake of 1,065 shares — an estimated $236K sold.

Shelton Capital Management first reported a position in MED in Q3 2018 and held it in 1 quarter. The position peaked at $236K in Q3 2018. 247 funds tracked by Wall St. Rank hold MED as of Q4 2018.

  • Shelton Capital Management reported no remaining Medifast position as of Q4 2018 after selling out during the quarter.
  • Shelton Capital Management sold 1,065 Medifast shares in Q4 2018, an estimated $236K.
  • Shelton Capital Management first reported a position in Medifast in Q3 2018 and held it in 1 quarter.
  • Shelton Capital Management's Medifast position peaked at $236K in Q3 2018.
  • 247 funds tracked by Wall St. Rank held Medifast as of Q4 2018.

Based on Shelton Capital Management's 13F filing for Q4 2018, filed 31 Jan 2019.